You haven't searched anything yet.
Apply now
Start
Date: Jun 20, 2024
Location: Indianapolis, Indiana, US
Company: Bureau Veritas
Company Overview:
ATL, A Bureau Veritas Company is a professional services organization with an ever-broadening service portfolio to support FDA-regulated products and companies worldwide. Providing scientific, engineering, and regulatory laboratory services, we seamlessly leverage our expertise within the consumer product goods, pharmaceutical, and medical device industries.
Headquartered in Cincinnati, Ohio, we are a highly profitable and nimble entrepreneurial organization comprised of nearly 500 experts who work throughout the United States. Anchored by the mission to add value to our clients throughout all stages of the product life cycle, we are the most desired business partner for our Fortune 500 clients.
Perks & Benefits at ATL:
Position Overview:
The primary responsibilities of the candidate will be to support the iPSC and cell therapy group in various activities including media preparation, culturing iPSCs and running iPSC differentiation studies to pancreatic islets. Additional responsibilities are supporting team members in executing assays such as qPCR, flow cytometry and gene editing. You will also be expected to work across groups and functions to enable assessments of differentiated cells.
What You’ll Do:
What You'll Need:
An equivalent combination of education and experience may be accepted in lieu of above.
AT ATL, we are an Equal Opportunity Employer and take pride in a diverse environment. We do not discriminate in recruitment, hiring, training, promotion, or other employment practices for reasons of race, color, religion, gender, sexual orientation, national origin, age, marital or veteran status, medical condition or disability, or any other legally protected status. ATL strongly supports diversity in the workplace.
Apply now
Start
Full Time
Business Services
$57k-74k (estimate)
05/24/2024
08/25/2024
group.bureauveritas.com
MANDEVILLE, LA
1,000 - 3,000
2002
$50M - $200M
Business Services